Full CoverageTop news
Johnson & Johnson vaccine should be paused in U.S. after 'extremely rare' blood clots, FDA and CDC say
By Erika Edwards, Alexander Smith & Amanda Golden
The Covid-19 vaccines are highly effective, and the chance of an adverse reaction is rare
By Scottie Andrew
CDC, FDA To Review J&J Shot After 6 Blood Clot Cases Reported Out Of Nearly 7M Doses
By Scott Neuman
All coverage
Johnson & Johnson COVID vaccine allotment will be 'relatively low' until Baltimore plant that ruined doses gets FDA ...
By Meredith Cohn & Hallie Miller
FDA advises states to pause use of J&J Covid vaccine after rare blood-clotting issue affects 6 women, kills 1
By Berkeley Lovelace, Berkeley Lovelace Jr. & Dawn Kopecki
Georgia becomes third state to shut down Johnson & Johnson vaccine site after adverse reactions
By Nikki Battiste
Johnson & Johnson vaccine deliveries plunge as company backs off previous April target
By Christopher Rowland
Covid-19: Johnson & Johnson Vaccine Pause Is Another Hurdle For Europe (Published 2021)
By Denise Grady, Asmaa Al-omar & Anna Schaverien
Johnson & Johnson vaccine paused over rare blood clots
By Rachel Schraer
U.S. states face steep decline in J&J Covid vaccine amid production problems at Baltimore plant
By Emma Newburger
U.S. Calls for Pause on Johnson & Johnson Vaccine After Blood Clotting Cases
By Sharon LaFraniere, Carl Zimmer & Noah Mercer Weiland
FDA, CDC call for pause in use of Johnson & Johnson vaccine after 'extremely rare' cases of blood clots
By Lena Sun, Carolyn Johnson & Laurie McGinley
